![Angelica Loskog](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Angelica Loskog
Direktor/Vorstandsmitglied bei
MEDIVIR AB
Vermögen: 1 286 $ am 31.08.2026
Profil
Angelica Loskog currently works at Lokon Pharma AB, as Chief Executive Officer & Director, Repos Pharma AB, as Chairman, Medivir AB, as Director from 2024, the University of Uppsala, as Associate Professor, and Nexttobe AB, as Scientific Adviser.
Dr. Loskog also formerly worked at Vivolux AB, as Chairman, Hansa Biopharma AB, as Independent Director from 2016 to 2019, and Bioimics AB, as Director.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.03.2026 | 6’309 ( 0% ) | 1 286 $ | 31.08.2026 |
Aktive Positionen von Angelica Loskog
| Unternehmen | Position | Beginn |
|---|---|---|
| MEDIVIR AB | Direktor/Vorstandsmitglied | 01.01.2024 |
Nexttobe AB
 Nexttobe AB Investment ManagersFinance Acts as an alternative investment manager | Technik-/Wissenschafts-/F&E-Leiter | - |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Lokon Pharma AB
 Lokon Pharma AB Miscellaneous Commercial ServicesCommercial Services Provides immunostimulatory gene therapy services | Vorstandsvorsitzender | - |
Repos Pharma AB | Vorsitzender | - |
Ehemalige bekannte Positionen von Angelica Loskog
| Unternehmen | Position | Ende |
|---|---|---|
| HANSA BIOPHARMA AB | Direktor/Vorstandsmitglied | 22.05.2019 |
Bioimics AB | Direktor/Vorstandsmitglied | - |
Vivolux AB
 Vivolux AB BiotechnologyHealth Technology Develops biotechnology for anticancer drugs | Vorsitzender | - |
Ausbildung von Angelica Loskog
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
75
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Medivir AB
 Medivir AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hansa Biopharma AB
 Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
Vivolux AB
Vivolux AB BiotechnologyHealth Technology Develops biotechnology for anticancer drugs | Health Technology |
Nexttobe AB
Nexttobe AB Investment ManagersFinance Acts as an alternative investment manager | Finance |
Bioimics AB | |
Lokon Pharma AB
Lokon Pharma AB Miscellaneous Commercial ServicesCommercial Services Provides immunostimulatory gene therapy services | Commercial Services |
Repos Pharma AB |
